Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.

Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev (2008) 5.28

Genome-wide association study of circulating vitamin D levels. Hum Mol Genet (2010) 4.07

Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst (2008) 3.60

The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev (2012) 2.71

The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials (2011) 2.59

Vitamin D deficiency in India: prevalence, causalities and interventions. Nutrients (2014) 1.94

Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev (2008) 1.80

Vitamin D: newly discovered actions require reconsideration of physiologic requirements. Trends Endocrinol Metab (2010) 1.68

The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women. Am J Epidemiol (2012) 1.62

Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res (2007) 1.54

Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila) (2009) 1.44

Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr (2008) 1.41

Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.40

Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort. Breast Cancer Res (2009) 1.33

The candidate oncogene CYP24A1: A potential biomarker for colorectal tumorigenesis. J Histochem Cytochem (2009) 1.30

Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: Implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinol (2011) 1.29

Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies. Medicine (Baltimore) (2013) 1.19

Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res (2008) 1.15

Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study. PLoS One (2011) 1.13

Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer Res (2010) 1.12

Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study. Am J Clin Nutr (2010) 1.12

Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D. Am J Public Health (2014) 1.10

Vitamin D status is associated with sociodemographic factors, lifestyle and metabolic health. Eur J Nutr (2012) 1.08

Lower vitamin-D production from solar ultraviolet-B irradiance may explain some differences in cancer survival rates. J Natl Med Assoc (2006) 1.07

The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control. Biochem Pharmacol (2009) 1.06

Criteria for the evaluation of large cohort studies: an application to the nurses' health study. J Natl Cancer Inst (2008) 1.06

Mammographic density, plasma vitamin D levels and risk of breast cancer in postmenopausal women. Int J Cancer (2010) 1.04

Vitamin D and the mammary gland: a review on its role in normal development and breast cancer. Breast Cancer Res (2012) 1.02

Vitamin d and serum cytokines in a randomized clinical trial. Int J Endocrinol (2010) 1.01

Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II. Breast Cancer Res (2011) 1.01

Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis. J Neurol (2011) 1.01

Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer. Endocrinology (2012) 1.00

Exploring the genetic architecture of circulating 25-hydroxyvitamin D. Genet Epidemiol (2012) 1.00

The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels. Ann Surg Oncol (2012) 1.00

Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancer. J Steroid Biochem Mol Biol (2010) 0.99

Assessment and interpretation of circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the clinical environment. Endocrinol Metab Clin North Am (2010) 0.98

Genetic and environmental predictors of serum 25-hydroxyvitamin D concentrations among middle-aged and elderly Chinese in Singapore. Br J Nutr (2012) 0.97

Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis. Br J Cancer (2014) 0.97

Vitamin D and breast cancer: interpreting current evidence. Breast Cancer Res (2011) 0.95

Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study. Breast Cancer Res (2013) 0.95

Vitamin D deficiency in newly diagnosed breast cancer patients. Indian J Endocrinol Metab (2012) 0.94

Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation. J Cell Physiol (2009) 0.94

25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1. Breast Cancer Res Treat (2012) 0.94

The effect of various vitamin D supplementation regimens in breast cancer patients. Breast Cancer Res Treat (2011) 0.94

Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S. Breast Cancer Res Treat (2011) 0.92

Higher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studies. PLoS One (2013) 0.91

Results of observational studies: analysis of findings from the Nurses' Health Study. PLoS One (2014) 0.91

Dietary vitamin D and calcium intake and mammographic density in postmenopausal women. Menopause (2010) 0.90

Vitamin D and calcium intake in relation to risk of endometrial cancer: a systematic review of the literature. Prev Med (2007) 0.89

The vitamin D pathway and mammographic breast density among postmenopausal women. Breast Cancer Res Treat (2011) 0.88

Vitamin D: marker or mechanism of action? Cancer Epidemiol Biomarkers Prev (2011) 0.88

Role of vitamin d in the prevention of pancreatic cancer. J Nutr Metab (2011) 0.88

Vitamin D and calcium supplementation and one-year change in mammographic density in the women's health initiative calcium and vitamin D trial. Cancer Epidemiol Biomarkers Prev (2012) 0.88

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes. J Cancer (2016) 0.87

Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer. Breast Cancer Res Treat (2014) 0.87

Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case-control study in the multiethnic cohort study. BMC Cancer (2014) 0.86

Plasma free 25-hydroxyvitamin D, vitamin D binding protein, and risk of breast cancer in the Nurses' Health Study II. Cancer Causes Control (2014) 0.86

The impact of delayed blood centrifuging, choice of collection tube, and type of assay on 25-hydroxyvitamin D concentrations. Cancer Causes Control (2009) 0.85

Does the evidence for an inverse relationship between serum vitamin D status and breast cancer risk satisfy the Hill criteria? Dermatoendocrinol (2012) 0.84

Transcriptional effects of 1,25 dihydroxyvitamin D(3) physiological and supra-physiological concentrations in breast cancer organotypic culture. BMC Cancer (2013) 0.84

Vitamin d: are we ready to supplement for breast cancer prevention and treatment? ISRN Oncol (2013) 0.83

Vitamin D3 regulates cell viability in gastric cancer and cholangiocarcinoma. Anat Cell Biol (2011) 0.83

Vitamin D and cancer: clinical aspects. Best Pract Res Clin Endocrinol Metab (2011) 0.83

Mechanistic Effects of Calcitriol in Cancer Biology. Nutrients (2015) 0.82

Vitamin D intake, month the mammogram was taken and mammographic density in Norwegian women aged 50-69. PLoS One (2015) 0.79

Low vitamin d status of patients in methadone maintenance treatment. J Addict Med (2009) 0.79

Hot flashes in breast cancer survivors and an association with calcium supplement use. Int J Womens Health (2010) 0.78

Role of local bioactivation of vitamin D by CYP27A1 and CYP2R1 in the control of cell growth in normal endometrium and endometrial carcinoma. Lab Invest (2014) 0.78

Surrogates of long-term vitamin d exposure and ovarian cancer risk in two prospective cohort studies. Cancers (Basel) (2013) 0.78

Current evidence on the four polymorphisms of VDR and breast cancer risk in Caucasian women. Meta Gene (2013) 0.78

The "Got D'ViBE?" study: an inter-institutional project assessing vitamin D and mammographic breast density. J Health Care Poor Underserved (2010) 0.77

Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years. Cancer Res (2016) 0.77

Physical activity, sedentary behavior, and vitamin D metabolites. Bone (2015) 0.76

Plasma insulin-like growth factor-1 level and risk of incident hypertension in nondiabetic women. J Hypertens (2011) 0.76

1α,25-Dihydroxyvitamin D Inhibits the Metastatic Capability of MCF10CA1a and MDA-MB-231 Cells in an In Vitro Model of Breast to Bone Metastasis. Nutr Cancer (2016) 0.75

Predicted 25-hydroxyvitamin D in relation to incidence of breast cancer in a large cohort of African American women. Breast Cancer Res (2016) 0.75

Independent and joint effects of serum 25-hydroxivitamin D and calcium on breast cancer ratio in an Iran population: A cross-sectional study. Niger Med J (2016) 0.75

Antiproliferative Effects of 1α-OH-vitD3 in Malignant Melanoma: Potential Therapeutic implications. Sci Rep (2017) 0.75

Increased vitamin D and calcium intake associated with reduced mammographic breast density among premenopausal women. Nutr Res (2015) 0.75

Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancer. J Cancer Res Clin Oncol (2016) 0.75

Effects of a parallel-arm randomized controlled weight loss pilot study on biological and psychosocial parameters of overweight and obese breast cancer survivors. Pilot Feasibility Stud (2017) 0.75

Pathway-based discovery of genetic interactions in breast cancer. PLoS Genet (2017) 0.75

Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science (2006) 18.74

Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65

Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94

Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34

Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med (2011) 12.29

Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA (2004) 11.69

Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr (2006) 10.95

Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA (2003) 10.05

Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst (2004) 8.77

Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71

Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med (2004) 8.63

Physical activity and survival after breast cancer diagnosis. JAMA (2005) 8.60

Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care (2010) 8.52

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39

The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer (2005) 8.19

25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med (2008) 8.03

Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72

The public health and economic benefits of taxing sugar-sweetened beverages. N Engl J Med (2009) 7.48

Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr (2002) 7.34

Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med (2002) 7.32

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30

Optimal diets for prevention of coronary heart disease. JAMA (2002) 7.24

Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19

Estimates of optimal vitamin D status. Osteoporos Int (2005) 7.13

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA (2006) 7.09

Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension (2007) 6.99

Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96

Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology (2008) 6.87

A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 6.85

Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr (2005) 6.67

Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67

Effect of Vitamin D on falls: a meta-analysis. JAMA (2004) 6.64

Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med (2014) 6.51

Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr (2003) 6.50

Insulin-like growth factors and neoplasia. Nat Rev Cancer (2004) 6.29

Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22

Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med (2012) 5.98

Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med (2003) 5.95

Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA (2005) 5.95

Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86

Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79

Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79

Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med (2004) 5.67

Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med (2009) 5.63

Alternative dietary indices both strongly predict risk of chronic disease. J Nutr (2012) 5.60

Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med (2005) 5.59

Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol (2006) 5.22

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14

The role of vitamin D in cancer prevention. Am J Public Health (2005) 4.99

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89

Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol (2008) 4.72

Red meat consumption and mortality: results from 2 prospective cohort studies. Arch Intern Med (2012) 4.72

Exercise type and intensity in relation to coronary heart disease in men. JAMA (2002) 4.69

Merging and emerging cohorts: not worth the wait. Nature (2007) 4.66

Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med (2009) 4.64

Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care (2006) 4.62

A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet (2008) 4.57

Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst (2004) 4.57

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54

Aspirin intake and survival after breast cancer. J Clin Oncol (2010) 4.50

Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care (2002) 4.48

Habitual caffeine intake and the risk of hypertension in women. JAMA (2005) 4.46

Increasing burden of melanoma in the United States. J Invest Dermatol (2009) 4.43

The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr (2007) 4.36

Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr (2004) 4.29

Dietary patterns, meat intake, and the risk of type 2 diabetes in women. Arch Intern Med (2004) 4.27

Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA (2011) 4.25

Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. Circulation (2012) 4.24

Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med (2002) 4.21

Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med (2002) 4.19

Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab (2007) 4.16

Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med (2006) 4.16

A new proposed guidance system for beverage consumption in the United States. Am J Clin Nutr (2006) 4.12

Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol (2007) 4.11

A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology (2013) 4.06

Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol (2005) 4.04

Comparison of risk factors for colon and rectal cancer. Int J Cancer (2004) 4.03

High school dietary dairy intake and teenage acne. J Am Acad Dermatol (2005) 4.00

Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst (2006) 3.96